淋巴浆细胞淋巴瘤中溶骨性骨病的管理：一例报告并文献复习
Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.
作者信息
Baksh Mizba, Jiang Liuyan, Bhatia Unnati, Alegria Victoria, Sher Taimur, Roy Vivek, Chanan-Khan Asher, Ailawadhi Sikander, Parrondo Ricardo D
机构信息
Division of Hematology-Oncology Mayo Clinic Jacksonville Florida USA.
Department of Pathology Mayo Clinic Jacksonville Florida USA.
出版信息
Clin Case Rep. 2021 Dec 7;9(12):e05181. doi: 10.1002/ccr3.5181. eCollection 2021 Dec.
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is often differentiated from myeloma based on the presence of lytic bone lesions (LBL). However, WM/LPL can present with LBL, and management is poorly understood. We describe a case of an 81-year-old woman with LPL who presented with LBL and was successfully treated with chemoimmunotherapy.
华氏巨球蛋白血症（WM）/淋巴浆细胞淋巴瘤（LPL）通常根据溶骨性骨病变（LBL）的存在与骨髓瘤相鉴别。然而，WM/LPL也可出现LBL，且对其治疗方法了解甚少。我们描述了一例81岁患有LPL的女性患者，该患者出现了LBL，并通过化疗免疫疗法成功治愈。
Zotero 插件